Addressing the Millions of Patients with Heart Failure with Preserved Ejection Fraction
Multiple risk factors lead to increase morbidity and mortality for patients. Risk Factors include:
References
1. Teramoto, K, et al. Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction. Cardiac Failure Review. 2022;8e27.
2. Clark, K. and Velazquez, E. Heart Failure with Preserved Ejection Fraction. JAMA. 2020;324(15):1506-1508.
3. Kataria, R. and Van Spall, H. Pharmacologic Treatment for HFpEF: Role of Drug Therapies at the Higher End of LVEF Spectrum. American Academy of Cardiology; Expert Analysis. 2022.
4. Borlaug, B. and Colucci, W. Treatment and Prognosis of Heart Failure with Preserved Ejection Fraction. UpToDate. September 30, 2022.
5. Hajouli, S. and Ludhwani, D. Heart Failure and Ejection Fraction. In: StatPearls Publishing; 2022; updated August 2022.